The University of Virginia has joined 99 other medical research facilities in testing a new drug that could help women who have lost interest in sex.
According to the Associated Press, researchers at the UVa Health System will begin prescribing a drug that uses the male hormone testosterone to heighten a woman's libido. About one-third of American women are believed to be affected by hypoactive sexual disorder, the decline in the desire for sexual activity.
The drug, called LibiGel and made by BioSante Pharmaceuticals Inc., is still being tested for safety and effectiveness before it is submitted to the US Food and Drug Administration for approval.
The UVa Health System testing isn't for the general population, Dr Anita Clayton, a psychiatrist who will supervise the study, told the AP.
Only 25 women between the ages of 30 and 65 will be enrolled, she said, and they must have had both ovaries surgically removed and be taking an oestrogen supplement. Finally, she said, they must display symptoms and concern about lack of sexual desire. – (HealthDay News)